Literature DB >> 18308900

Focus on geriatric psychiatry: schizophrenia in later life: clinical symptoms and social well-being.

Carl I Cohen1, Ipsit Vahia, Pia Reyes, Shilpa Diwan, Azziza O Bankole, Nikhil Palekar, Michelle Kehn, Paul Ramirez.   

Abstract

The number of persons aged 55 and older with a diagnosis of schizophrenia is projected to double over the next 20 years. A tripartite classification system of early-onset schizophrenia, late-onset schizophrenia, and very-late-onset schizophrenia-like psychosis has been proposed. This column reviews recent findings on the outcome and associated features of clinical symptom and social well-being categories for older adults with early-onset schizophrenia.

Entities:  

Mesh:

Year:  2008        PMID: 18308900     DOI: 10.1176/ps.2008.59.3.232

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  22 in total

Review 1.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

2.  Suicide attempts and associated factors in older adults with schizophrenia.

Authors:  Carl I Cohen; Chadi G Abdallah; Shilpa Diwan
Journal:  Schizophr Res       Date:  2010-04-10       Impact factor: 4.939

Review 3.  Cognition, function, and disability in patients with schizophrenia: a review of longitudinal studies.

Authors:  Tarek K Rajji; Dielle Miranda; Benoit H Mulsant
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

4.  Play provides social connection for older adults with serious mental illness: A grounded theory analysis of a 10-week exergame intervention.

Authors:  Sarah Dobbins; Erin Hubbard; Annesa Flentje; Carol Dawson-Rose; Heather Leutwyler
Journal:  Aging Ment Health       Date:  2018-12-27       Impact factor: 3.658

Review 5.  Management of schizophrenia in late life with antipsychotic medications: a qualitative review.

Authors:  Takefumi Suzuki; Gary Remington; Hiroyuki Uchida; Tarek K Rajji; Ariel Graff-Guerrero; David C Mamo
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

6.  "Looking Forward": a qualitative evaluation of a physical activity program for middle-aged and older adults with serious mental illness.

Authors:  Sarah Dobbins; Erin Hubbard; Heather Leutwyler
Journal:  Int Psychogeriatr       Date:  2019-08-28       Impact factor: 3.878

Review 7.  New wine in old bottle: late-life psychosis.

Authors:  Alana Iglewicz; Thomas W Meeks; Dilip V Jeste
Journal:  Psychiatr Clin North Am       Date:  2011-06

8.  Subjective reasons for adherence to psychotropic medication and associated factors among older adults with schizophrenia.

Authors:  Mamta Sapra; Ipsit V Vahia; Pia N Reyes; Paul Ramirez; Carl I Cohen
Journal:  Schizophr Res       Date:  2008-10-11       Impact factor: 4.939

9.  Impact of age and CYP2D6 genotype on exposure of zuclopenthixol in patients using long-acting injectable versus oral formulation-an observational study including 2044 patients.

Authors:  Marit Tveito; Robert Løvsletten Smith; Espen Molden; Gudrun Høiseth
Journal:  Eur J Clin Pharmacol       Date:  2020-09-30       Impact factor: 2.953

10.  The impact of aging, cognition, and symptoms on functional competence in individuals with schizophrenia across the lifespan.

Authors:  Sawsan M Kalache; Benoit H Mulsant; Simon J C Davies; Angela Y Liu; Aristotle N Voineskos; Meryl A Butters; Dielle Miranda; Mahesh Menon; Robert S Kern; Tarek K Rajji
Journal:  Schizophr Bull       Date:  2014-08-06       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.